4//SEC Filing
Kerstein David 4
Accession 0001104659-23-023507
CIK 0001745020other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:03 AM ET
Size
5.5 KB
Accession
0001104659-23-023507
Insider Transaction Report
Form 4
Kerstein David
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-17+105,000→ 105,000 totalExercise: $11.42Exp: 2033-02-17→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 25% of the options vesting on February 17, 2024 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.
Documents
Issuer
Theseus Pharmaceuticals, Inc.
CIK 0001745020
Entity typeother
Related Parties
1- filerCIK 0001796388
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 7:03 AM ET
- Size
- 5.5 KB